Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Schafer JoshuaCCO |  ZVRAZEVRA THERAPEUTICS, INC.Open-market sale · 10b5-1 plan | SELL | $97K 10.5K sh | Feb 4, 2026 |
| 12 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $34K 736 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 11 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 600 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 11 | Holleran KevinDirector, President and CEO |  HAYWHayward Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $841K 52.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 10 | Rucci Carolyn M.SVP, Chief Legal Officer |  AKBAAkebia Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $38K 27.5K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 10 | Alpern Paul LVP and General Counsel |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $77K 5,000 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 10 | Rucci Carolyn M.SVP, Chief Legal Officer | AKBAAkebia Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 16.8K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 10 | Rucci Carolyn M.SVP, Chief Legal Officer | AKBAAkebia Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $35K 25.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 10 | Malabre Richard CSVP, Chief Accounting Officer | AKBAAkebia Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 13.4K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Feierstein Matthew DavidPresident |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $121K 10.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 9 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $102K 9,280 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 8 | Gummadi SuryaPresident - Americas | CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP Open-market sale · 10b5-1 plan | SELL | $144K 1,728 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $8,830 200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 8 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $139K 5,262 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $159K 14.7K sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $8,388 720 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $108K 10.0K sh | Feb 4, 2026 traded Feb 4, 2026 |
| 5 | Saldanha CraigChief Product Officer |  YELPYELP INCOpen-market sale · 10b5-1 plan | SELL | $33K 1,200 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Vultaggio VincentPAO and PFO |  ZNTLZentalis Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $6,477 2,540 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $20K 1,700 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 3 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $30K 2,797 sh | Feb 4, 2026 traded Feb 4, 2026 |
| 1 | Sieffert Kristen NPresident |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $17K 750 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $75K 381 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 1 | Vultaggio VincentPAO and PFO | ZNTLZentalis Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $1,398 556 sh | Feb 4, 2026 traded Feb 3, 2026 |
| 1 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 30.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $192 1 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $7,449 39 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,499 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 0 | Kozarich John WDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $4,535 23 sh | Feb 4, 2026 traded Feb 2, 2026 |
| 37 | Running Michael J.Regional President - AMER |  PLXSPLEXUS CORPOpen-market sale | SELL | $190K 926 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $117K 1,166 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 33 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $165K 1,662 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 30 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $49K 492 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 29 | Lee David EricVICE CHAIR, WINTRUST FINANCIAL |  WTFCWINTRUST FINANCIAL CORPOpen-market sale | SELL | $82K 558 sh | Feb 3, 2026 traded Jan 30, 2026 |
| 26 | Dechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale | SELL | $8,999 93 sh | Feb 3, 2026 traded Feb 2, 2026 |
| 19 | Robinson Jill L.EVP, CFO & Treasurer |  BATRKAtlanta Braves Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $800K 20.0K sh | Feb 3, 2026 traded Feb 2, 2026 |
| 10 | Smith Chad M.Pres & COO, Better Mortgage |  BETRBetter Home & Finance Holding CoOpen-market sale · 10b5-1 plan | SELL | $84K 3,097 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 10 | Malcolm JanDirector |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $24K 50 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 9 | Ohlgart ChristianeChief Financial Officer |  FTNTFortinet, Inc.Open-market sale · 10b5-1 plan | SELL | $41K 507 sh | Feb 3, 2026 traded Feb 3, 2026 |
| 6 | Jedrzejek DavidSVP and General Counsel |  LEVILEVI STRAUSS & COOpen-market sale · 10b5-1 plan | SELL | $44K 2,248 sh | Feb 3, 2026 traded Feb 3, 2026 |